Working diligently since the early 1990s to perfect KNOSIS, its proprietary platform technology, Strategic Science & Technologies, Inc. (SSTI) and Strategic Science & Technologies, LLC, (SST) have created and assembled an intellectual property portfolio that is both comprehensive and unique. Many of the assets contained in the Company's impressive and ever-growing portfolio offer enormous commercial potential to pharmaceutical and life science companies wishing to possess the ability to deliver pharmaceutical agents transdermally. A list of patents that have been issued can be accessed here.